The PI3K/Akt/mTOR axis is of particular interest due to its central role in NB cell growth, proliferation and survival, and in MYCN potentiation10–13; and PI3K/mTOR/Akt inhibitors have shown efficacy in MYCN degradation in several NB animal models9,14,15. The gene discussed is MYCN; the disease is neuroblastoma.